NGS Kits Market Forecasts Growth from $6.84 Billion (2025) to $19.36 Billion by 2036, Profiling Illumina, Thermo Fisher Scientific, Roche, Oxford Nanopore & 11 Other Key Players

NGS Kits Market Forecasts Growth from $6.84 Billion (2025) to $19.36 Billion by 2036, Profiling Illumina, Thermo Fisher Scientific, Roche, Oxford Nanopore & 11 Other Key Players Dublin, Oct. 23, 2026 (GLOBE NEWSWIRE) -- "NGS Kits Market: Focus on Workflow, Sequencing Type, Application, End User, and Regional Analysis - Analysis and Forecast Year, 2026-2036" has been added to ResearchAndMarkets.com's offering.

The global NGS kits market was valued at $6,843.4 million in 2025 and is projected to reach $19,356.9 million by 2036, expanding at a CAGR of 10.09% during 2026-2036. Growth is being driven by the integration of next-generation sequencing into genomics research, precision oncology, rare-disease investigation, reproductive health, infectious-disease surveillance, population genomics, and biopharmaceutical development.

Rising sample volumes, wider access to sequencing infrastructure, and the transition from single-gene testing to multigene, exome, and genome-scale analysis are increasing recurring demand for library preparation kits, target enrichment products, cluster-generation consumables, sequencing reagents, flow cells, cartridges, controls, and indexing products. Academic core facilities, clinical laboratories, pharmaceutical and biotechnology companies, public-health organizations, and national genomics programs are expanding sequencing capacity and supporting repeat consumables purchasing.

Market Scope and Technology Trends

The report covers commercially supplied NGS consumables used in research, translational studies, authorized in vitro diagnostic workflows, and internally validated laboratory-developed test workflows. It excludes sequencing instruments, standalone sequencing services, bioinformatics, data interpretation, and laboratory testing revenue. Although these activities fall outside the market calculation, the installed sequencing base, clinical-laboratory capacity, and expansion of validated testing menus remain major demand enablers.

Laboratories increasingly require high-throughput, multiplexed, automated, low-input, and application-specific workflows. Demand is particularly strong for kits that reduce hands-on time, support large index sets, simplify cleanup, use smaller reaction volumes, and deliver consistent performance with cell-free DNA, FFPE tissue, single cells, microbial samples, and limited clinical specimens.

Purchasing decisions are influenced by accuracy, sample-input flexibility, automation compatibility, platform alignment, pricing, regulatory readiness, technical support, and supply reliability. Lot-to-lot performance is especially important in regulated and high-throughput environments, where interruptions can delay research programs, assay validation, and patient-facing laboratory operations. Suppliers are responding with integrated chemistries, automation-ready protocols, higher multiplexing capacity, faster turnaround, and broader application menus.

Market Segmentation Highlights

Europe remains a significant market due to its genomics institutes, biobanks, clinical research networks, and coordinated cancer and rare-disease initiatives. Latin America and the Rest-of-the-World offer developing opportunities as laboratory infrastructure, technical training, funding, and distributor coverage improve.

Market Drivers, Challenges, and Opportunities

Routine clinical integration of NGS into funded diagnostic pathways is a major market driver. Oncology generates substantial recurring consumption through tumor classification, therapy selection, clinical-trial matching, and resistance assessment. Rare-disease, inherited-disorder, and reproductive-health testing also supports demand for exome, genome, family-indexing, and cell-free DNA workflows.

Public genomics and pathogen-surveillance programs provide another source of recurring procurement. Population cohorts require large-scale whole-genome, exome, RNA, and long-read sequencing, while surveillance networks support testing for viral, bacterial, fungal, parasitic, foodborne, and antimicrobial-resistance threats. Ordering patterns may remain uneven because procurement depends on funding cycles, cohort milestones, outbreaks, laboratory capacity, and specimen availability.

Market expansion is constrained by fragmented reimbursement, regulatory, and validation requirements. Differences in authorization pathways, payer coverage, specimen requirements, intended use, and evidence standards can delay clinical adoption. Preparation complexity, consumables costs, cold-chain logistics, specialized expertise, and protocol transfer between platforms can also affect throughput and purchasing decisions.

Genome-first newborn and population screening represents a notable long-term opportunity. Transitioning these programs from pilot studies to routine care could generate recurring demand for whole-genome library kits, indexes, sequencing reagents, flow cells, controls, and confirmatory products. Adoption will depend on clinical utility, actionable findings, consent frameworks, turnaround time, data governance, treatment pathways, and sustainable reimbursement.

Recent NGS Kits Market Developments

Competitive Landscape

Competition in the NGS kits market is shaped by sequencing accuracy, throughput, turnaround time, workflow simplicity, automation compatibility, sample-input requirements, cost per sample, technical support, and supply continuity. Platform providers compete through proprietary chemistries and recurring reagent ecosystems, while independent suppliers differentiate through target enrichment, library preparation, multiplexing, custom assay development, and flexible platform compatibility.

Prominent companies include Illumina, Inc., Agilent Technologies, Inc., F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Inc., QIAGEN N.V., Takara Bio Inc., Oxford Nanopore Technologies plc, Thermo Fisher Scientific Inc., Danaher Corporation, Pacific Biosciences of California, Inc., MGI Tech Co., Ltd., New England Biolabs, Inc., Twist Bioscience Corporation, seqWell, Inc., Promega Corporation, and Creative Biogene.

The report supports product development, commercialization, and competitive planning by evaluating the market across workflow, application, sequencing type, end user, and region. It helps organizations identify portfolio gaps, prioritize automation and sample compatibility, assess platform alignment, target high-growth customer groups, evaluate geographic expansion, and strengthen positioning in research and clinical NGS workflows.

Key Topics Covered:

Executive Summary

Scope and Definition

1 Global NGS Kits Market: Industry Outlook

1.1 Market Overview and Ecosystem

1.1.1 Introduction

1.1.2 Evolution of NGS Technology

1.1.3 Workflow of NGS Kits

1.1.4 Patent Analysis

1.1.4.1 Patent Filing Trend by Region

1.1.4.2 Patent Filing Trend by Country

1.1.4.3 Patent Filing Trend (by Year)

1.1.5 Supply Chain Analysis

1.1.6 Trends: Current and Future Impact Assessment

1.1.6.1 Impact Analysis

1.1.6.1.1 Shift toward Higher-Throughput, Automated, Miniaturized, and Flexible Sequencing Workflows

1.1.6.1.2 Growing Long-Read Share and Increasing Use of Multi-Platform Sequencing Portfolios

1.1.6.1.3 Shift toward Broader Combined DNA/RNA and Liquid-Biopsy-Compatible Assay Designs

1.1.7 Regulatory Landscape

1.1.7.1 North America

1.1.7.1.1 U.S.

1.1.7.1.2 Canada

1.1.7.2 Europe

1.1.7.2.1 European Union

1.1.7.2.2 U.K.

1.1.7.3 Asia-Pacific

1.1.7.3.1 Japan

1.1.7.3.2 China

1.1.7.3.3 India

1.1.7.3.4 Rest-of-Asia-Pacific

1.1.7.4 Latin America

1.1.7.4.1 Brazil

1.1.7.4.2 Mexico

1.1.7.5 Rest-of-the-World

1.2 Market Dynamics

1.2.1 Market Drivers

1.2.1.1 Routine Clinical NGS Integration across Established Diagnostic Pathways Expands Recurring Kit Consumption

1.2.1.2 Active Public Genomics and Pathogen-Surveillance Programs Sustain Programmatic Consumables Procurement

1.2.1.3 Biomarker-Driven Drug Development and NGS Companion-Diagnostic Co-Development Generate Pharmaceutical and Central-Laboratory Kit Demand

1.2.2 Market Restraints

1.2.2.1 Fragmented Reimbursement, Regulatory, and Validation Requirements Delay Clinical Adoption and Market Access

1.2.2.2 High End-to-End Implementation Burden and Limited Laboratory Capacity Constrain Sequencing Utilization

1.2.2.3 Trade Restrictions and Platform-Specific Supply Dependencies Limit Regional Consumables Access

1.2.3 Market Opportunities

1.2.3.1 Scaling Genome-First Newborn and Population Screening from Pilots into Routine Care

1.2.3.2 Decentralized Clinical NGS Expansion across Underpenetrated Countries and Regional Laboratories

1.2.3.3 Clinical Adoption of Long-Read Sequencing for Unresolved and Complex Disease Workflows

2 Global NGS Kits Market (by Workflow), $Million, 2024-2036

2.1 Library Preparation

2.1.1 Overview

2.1.2 Market Sizing and Forecast

2.1.3 Library Preparation Kits

2.1.3.1 Market Sizing and Forecast

2.1.4 Target Enrichment Kits

2.1.4.1 Market Sizing and Forecast

2.2 Cluster Generation

2.2.1 Overview

2.2.2 Market Sizing and Forecast

2.3 Sequencing Reagents/Kits

2.3.1 Overview

2.3.2 Market Sizing and Forecast

2.3.3 DNA Sequencing Kits

2.3.3.1 Market Sizing and Forecast

2.3.4 RNA Sequencing Kits

2.3.4.1 Market Sizing and Forecast

3 Global NGS Kits Market (by Sequencing Type), $Million, 2024-2036

3.1 WES and WGS

3.1.1 Overview

3.1.2 Market Sizing and Forecast

3.2 Targeted Sequencing

3.2.1 Overview

3.2.2 Market Sizing and Forecast

3.3 Long-Read Sequencing

3.3.1 Overview

3.3.2 Market Sizing and Forecast

3.4 Other Sequencing

3.4.1 Overview

3.4.2 Market Sizing and Forecast

4 Global NGS Kits Market (by Application), $Million, 2024-2036

4.1 Oncology

4.1.1 Overview

4.1.2 Market Sizing and Forecast

4.1.3 Solid Tumors

4.1.3.1 Market Sizing and Forecast

4.1.4 Hematological Malignancies

4.1.4.1 Market Sizing and Forecast

4.2 Rare Diseases

4.2.1 Overview

4.2.2 Market Sizing and Forecast

4.3 Genetic Disorders

4.3.1 Overview

4.3.2 Market Sizing and Forecast

4.4 Reproductive Health

4.4.1 Overview

4.4.2 Market Sizing and Forecast

4.5 Infectious Diseases

4.5.1 Overview

4.5.2 Market Sizing and Forecast

4.5.3 Viral Infections

4.5.3.1 Market Sizing and Forecast

4.5.4 Bacterial Infections

4.5.4.1 Market Sizing and Forecast

4.5.5 Fungal and Parasitic Infections

4.5.5.1 Market Sizing and Forecast

4.6 Others

4.6.1 Overview

4.6.2 Market Sizing and Forecast

5 Global NGS Kits Market (by End User), $Million, 2024-2036

5.1 Academic and Research Institutes

5.1.1 Overview

5.1.2 Market Sizing and Forecast

5.2 Pharmaceutical and Biotechnology Companies

5.2.1 Overview

5.2.2 Market Sizing and Forecast

5.3 Clinical and Diagnostic Laboratories

5.3.1 Overview

5.3.2 Market Sizing and Forecast

5.4 Other End Users

5.4.1 Overview

5.4.2 Market Sizing and Forecast

6 Global NGS Kits Market (by Region), $Million, 2024-2036

6.1 Regional Summary

6.2 North America

6.2.1 Regional Overview

6.2.2 Driving Factors for Market Growth

6.2.3 Factors Challenging the Market

6.2.4 Analyst View

6.2.5 Market Sizing and Forecast

6.2.5.1 North America NGS Kits Market, by Application

6.2.5.2 North America NGS Kits Market, by End User

6.2.5.3 North America NGS Kits Market, by Country

6.2.5.3.1 U.S.

6.2.5.3.1.1 Country Overview

6.2.5.3.1.2 Driving Factors for Market Growth

6.2.5.3.1.3 Factors Challenging the Market

6.2.5.3.1.4 Analyst View

6.2.5.3.1.5 Market Sizing and Forecast

6.2.5.3.1.5.1 U.S. NGS Kits Market, by Application

6.2.5.3.1.5.2 U.S. NGS Kits Market, by End User

6.2.5.3.2 Canada

6.2.5.3.2.1 Country Overview

6.2.5.3.2.2 Driving Factors for Market Growth

6.2.5.3.2.3 Factors Challenging the Market

6.2.5.3.2.4 Analyst View

6.2.5.3.2.5 Market Sizing and Forecast

6.2.5.3.2.5.1 Canada NGS Kits Market, by Application

6.2.5.3.2.5.2 Canada NGS Kits Market, by End User

6.3 Europe

6.3.1 Regional Overview

6.3.2 Driving Factors for Market Growth

6.3.3 Factors Challenging the Market

6.3.4 Analyst View

6.3.5 Market Sizing and Forecast

6.3.5.1 Europe NGS Kits Market, by Application

6.3.5.2 Europe NGS Kits Market, by End User

6.3.5.3 Europe NGS Kits Market, by Country

6.3.5.3.1 Germany

6.3.5.3.1.1 Country Overview

6.3.5.3.1.2 Driving Factors for Market Growth

6.3.5.3.1.3 Factors Challenging the Market

6.3.5.3.1.4 Analyst View

6.3.5.3.1.5 Market Sizing and Forecast

6.3.5.3.1.5.1 Germany NGS Kits Market, by Application

6.3.5.3.1.5.2 Germany NGS Kits Market, by End User

6.3.5.3.2 France

6.3.5.3.2.1 Country Overview

6.3.5.3.2.2 Driving Factors for Market Growth

6.3.5.3.2.3 Factors Challenging the Market

6.3.5.3.2.4 Analyst View

6.3.5.3.2.5 Market Sizing and Forecast

6.3.5.3.2.5.1 France NGS Kits Market, by Application

6.3.5.3.2.5.2 France NGS Kits Market, by End User

6.3.5.3.3 U.K.

6.3.5.3.3.1 Country Overview

6.3.5.3.3.2 Driving Factors for Market Growth

6.3.5.3.3.3 Factors Challenging the Market

6.3.5.3.3.4 Analyst View

6.3.5.3.3.5 Market Sizing and Forecast

6.3.5.3.3.5.1 U.K. NGS Kits Market, by Application

6.3.5.3.3.5.2 U.K. NGS Kits Market, by End User

6.3.5.3.4 Italy

6.3.5.3.4.1 Country Overview

6.3.5.3.4.2 Driving Factors for Market Growth

6.3.5.3.4.3 Factors Challenging the Market

6.3.5.3.4.4 Analyst View

6.3.5.3.4.5 Market Sizing and Forecast

6.3.5.3.4.5.1 Italy NGS Kits Market, by Application

6.3.5.3.4.5.2 Italy NGS Kits Market, by End User

6.3.5.3.5 Spain

6.3.5.3.5.1 Country Overview

6.3.5.3.5.2 Driving Factors for Market Growth

6.3.5.3.5.3 Factors Challenging the Market

6.3.5.3.5.4 Analyst View

6.3.5.3.5.5 Market Sizing and Forecast

6.3.5.3.5.5.1 Spain NGS Kits Market, by Application

6.3.5.3.5.5.2 Spain NGS Kits Market, by End User

6.3.5.3.6 Rest-of-Europe

6.3.5.3.6.1 Country Overview

6.3.5.3.6.2 Driving Factors for Market Growth

6.3.5.3.6.3 Factors Challenging the Market

6.3.5.3.6.4 Analyst View

6.3.5.3.6.5 Market Sizing and Forecast

6.3.5.3.6.5.1 Rest-of-Europe NGS Kits Market, by Application

6.3.5.3.6.5.2 Rest-of-Europe NGS Kits Market, by End User

6.4 Asia-Pacific

6.4.1 Regional Overview

6.4.2 Driving Factors for Market Growth

6.4.3 Factors Challenging the Market

6.4.4 Analyst View

6.4.5 Market Sizing and Forecast

6.4.5.1 Asia-Pacific NGS Kits Market, by Application

6.4.5.2 Asia-Pacific NGS Kits Market, by End User

6.4.5.3 Asia-Pacific NGS Kits Market, by Country

6.4.5.3.1 China

6.4.5.3.1.1 Country Overview

6.4.5.3.1.2 Driving Factors for Market Growth

6.4.5.3.1.3 Factors Challenging the Market

6.4.5.3.1.4 Analyst View

6.4.5.3.1.5 Market Sizing and Forecast

6.4.5.3.1.5.1 China NGS Kits Market, by Application

6.4.5.3.1.5.2 China NGS Kits Market, by End User

6.4.5.3.2 Japan

6.4.5.3.2.1 Country Overview

6.4.5.3.2.2 Driving Factors for Market Growth

6.4.5.3.2.3 Factors Challenging the Market

6.4.5.3.2.4 Analyst View

6.4.5.3.2.5 Market Sizing and Forecast

6.4.5.3.2.5.1 Japan NGS Kits Market, by Application

6.4.5.3.2.5.2 Japan NGS Kits Market, by End User

6.4.5.3.3 India

6.4.5.3.3.1 Country Overview

6.4.5.3.3.2 Driving Factors for Market Growth

6.4.5.3.3.3 Factors Challenging the Market

6.4.5.3.3.4 Analyst View

6.4.5.3.3.5 Market Sizing and Forecast

6.4.5.3.3.5.1 India NGS Kits Market, by Application

6.4.5.3.3.5.2 India NGS Kits Market, by End User

6.4.5.3.4 Australia

6.4.5.3.4.1 Country Overview

6.4.5.3.4.2 Driving Factors for Market Growth

6.4.5.3.4.3 Factors Challenging the Market

6.4.5.3.4.4 Analyst View

6.4.5.3.4.5 Market Sizing and Forecast

6.4.5.3.4.5.1 Australia NGS Kits Market, by Application

6.4.5.3.4.5.2 Australia NGS Kits Market, by End User

6.4.5.3.5 South Korea

6.4.5.3.5.1 Country Overview

6.4.5.3.5.2 Driving Factors for Market Growth

6.4.5.3.5.3 Factors Challenging the Market

6.4.5.3.5.4 Analyst View

6.4.5.3.5.5 Market Sizing and Forecast

6.4.5.3.5.5.1 South Korea NGS Kits Market, by Application

6.4.5.3.5.5.2 South Korea NGS Kits Market, by End User

6.4.5.3.6 Rest-of-Asia-Pacific

6.4.5.3.6.1 Country Overview

6.4.5.3.6.2 Driving Factors for Market Growth

6.4.5.3.6.3 Factors Challenging the Market

6.4.5.3.6.4 Analyst View

6.4.5.3.6.5 Market Sizing and Forecast

6.4.5.3.6.5.1 Rest-of-Asia-Pacific NGS Kits Market, by Application

6.4.5.3.6.5.2 Rest-of-Asia-Pacific NGS Kits Market, by End User

6.5 Latin America

6.5.1 Regional Overview

6.5.2 Driving Factors for Market Growth

6.5.3 Factors Challenging the Market

6.5.4 Analyst View

6.5.5 Market Sizing and Forecast

6.5.5.1 Latin America NGS Kits Market, by Application

6.5.5.2 Latin America NGS Kits Market, by End User

6.5.5.3 Latin America NGS Kits Market, by Country

6.5.5.3.1 Brazil

6.5.5.3.1.1 Country Overview

6.5.5.3.1.2 Driving Factors for Market Growth

6.5.5.3.1.3 Factors Challenging the Market

6.5.5.3.1.4 Analyst View

6.5.5.3.1.5 Market Sizing and Forecast

6.5.5.3.1.5.1 Brazil NGS Kits Market, by Application

6.5.5.3.1.5.2 Brazil NGS Kits Market, by End User

6.5.5.3.2 Mexico

6.5.5.3.2.1 Country Overview

6.5.5.3.2.2 Driving Factors for Market Growth

6.5.5.3.2.3 Factors Challenging the Market

6.5.5.3.2.4 Analyst View

6.5.5.3.2.5 Market Sizing and Forecast

6.5.5.3.2.5.1 Mexico NGS Kits Market, by Application

6.5.5.3.2.5.2 Mexico NGS Kits Market, by End User

6.5.5.3.3 Rest-of-Latin America

6.5.5.3.3.1 Country Overview

6.5.5.3.3.2 Driving Factors for Market Growth

6.5.5.3.3.3 Factors Challenging the Market

6.5.5.3.3.4 Analyst View

6.5.5.3.3.5 Market Sizing and Forecast

6.5.5.3.3.5.1 Rest-of-Latin America NGS Kits Market, by Application

6.5.5.3.3.5.2 Rest-of-Latin-America NGS Kits Market, by End User

6.6 Rest-of-the-World

6.6.1 Regional Overview

6.6.2 Driving Factors for Market Growth

6.6.3 Factors Challenging the Market

6.6.4 Analyst View

6.6.5 Market Sizing and Forecast

6.6.5.1 Rest-of-the-World NGS Kits Market, by Application

6.6.5.2 Rest-of-the-World NGS Kits Market, by End User

7 Competitive Benchmarking and Company Profiles

7.1 Key Strategies and Developments

7.1.1 New Offerings

7.1.2 Mergers and Acquisitions

7.1.3 Partnership, Alliances, and Business Expansion

7.2 Company Profiles

7.2.1 Bio-Rad Laboratories, Inc.

7.2.1.1 Overview

7.2.1.2 Top Products/Product Portfolio

7.2.1.3 Target Customers/End-User

7.2.1.4 Key Personnel

7.2.1.5 Analyst View

7.2.2 MGI Tech Co., Ltd.

7.2.2.1 Overview

7.2.2.2 Top Products/Product Portfolio

7.2.2.3 Target Customers/End-User

7.2.2.4 Key Personnel

7.2.2.5 Analyst View

7.2.3 F. Hoffmann-La Roche Ltd.

7.2.3.1 Overview

7.2.3.2 Top Products/Product Portfolio

7.2.3.3 Target Customers/End-User

7.2.3.4 Key Personnel

7.2.3.5 Analyst View

7.2.4 Agilent Technologies, Inc.

7.2.4.1 Overview

7.2.4.2 Top Products/Product Portfolio

7.2.4.3 Target Customers/End-User

7.2.4.4 Key Personnel

7.2.4.5 Analyst View

7.2.5 QIAGEN N.V.

7.2.5.1 Overview

7.2.5.2 Top Products/Product Portfolio

7.2.5.3 Target Customers/End-User

7.2.5.4 Key Personnel

7.2.5.5 Analyst View

7.2.6 Thermo Fisher Scientific Inc.

7.2.6.1 Overview

7.2.6.2 Top Products/Product Portfolio

7.2.6.3 Target Customers/End-User

7.2.6.4 Key Personnel

7.2.6.5 Analyst View

7.2.7 Danaher Corporation

7.2.7.1 Overview

7.2.7.2 Top Products/Product Portfolio

7.2.7.3 Target Customers/End-User

7.2.7.4 Key Personnel

7.2.7.5 Analyst View

7.2.8 Illumina, Inc.

7.2.8.1 Overview

7.2.8.2 Top Products/Product Portfolio

7.2.8.3 Target Customers/End-User

7.2.8.4 Key Personnel

7.2.8.5 Analyst View

7.2.9 New England Biolabs, Inc.

7.2.9.1 Overview

7.2.9.2 Top Products/Product Portfolio

7.2.9.3 Target Customers/End-User

7.2.9.4 Key Personnel

7.2.9.5 Analyst View

7.2.10 Oxford Nanopore Technologies plc

7.2.10.1 Overview

7.2.10.2 Top Products/Product Portfolio

7.2.10.3 Target Customers/End-User

7.2.10.4 Key Personnel

7.2.10.5 Analyst View

7.2.11 Pacific Biosciences of California, Inc.

7.2.11.1 Overview

7.2.11.2 Top Products/Product Portfolio

7.2.11.3 Target Customers/End-User

7.2.11.4 Key Personnel

7.2.11.5 Analyst View

7.2.12 Revvity, Inc.

7.2.12.1 Overview

7.2.12.2 Top Products/Product Portfolio

7.2.12.3 Target Customers/End-User

7.2.12.4 Key Personnel

7.2.12.5 Analyst View

7.2.13 Twist Bioscience Corporation

7.2.13.1 Overview

7.2.13.2 Top Products/Product Portfolio

7.2.13.3 Target Customers/End-User

7.2.13.4 Key Personnel

7.2.13.5 Analyst View

7.2.14 seqWell, Inc.

7.2.14.1 Overview

7.2.14.2 Top Products/Product Portfolio

7.2.14.3 Target Customers/End-User

7.2.14.4 Key Personnel

7.2.14.5 Analyst View

7.2.15 Takara Bio Inc.

7.2.15.1 Overview

7.2.15.2 Top Products/Product Portfolio

7.2.15.3 Target Customers/End-User

7.2.15.4 Key Personnel

7.2.15.5 Analyst View

8 Research Methodology

8.1 Data Sources

8.1.1 Primary Data Sources

8.1.2 Secondary Data Sources

8.1.3 Data Triangulation

8.2 Market Estimation and Forecast

List of Figures [66]

List of Tables [54]

Companies Featured

For more information about this report visit https://www.researchandmarkets.com/r/o008ao

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.